Resiniferatoxin
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Apr 1, 2016 (NCT02566564)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lopain
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05449132 | Phase 3 | Jul 10, 2022 | Grunenthal |
| NCT05377489 | Phase 3 | Jun 30, 2022 | Grunenthal |
| NCT05248386 | Phase 3 | May 31, 2022 | Grunenthal |
| NCT02566564 | Phase 1 | Apr 1, 2016 | Mestex AG, SGS Life Sciences |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Grunenthal | For profit | 3 | 3 | 1 | 2022 |
| Mestex AG | For profit | 1 | 1 | 1 | 2016 |
| SGS Life Sciences | For profit | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1